Scientific/User
Transcription
Scientific/User
Devices and Manufacturing Equipment Used for Production of Immune Cell Therapy and Cell Expansion: Scientific/User Issues Bruce Levine, Ph.D. Department of Pathology and Laboratory Medicine University of Pennsylvania Activated T Cell Therapy for Infection or Malignancy Cell Processing 1. Obtain cells from patient and enrich or isolate particular cells of interest 6. Quality Control Reinfuse cells 5. Remove beads and Bead 2. Stimulate cells to grow wash cells 3. Insert potentially therapeutic genes into cells 4. Large scale cell expansion Activated T Cell Processing Flow Day 0 Leukocyte Apheresis Day ~10 Remove Beads (Baxter Maxsep) Harvester (Baxter Fenwal) Gambro Elutra depletion of monocytes Day 3 to 5 Seed WAVE Bioreactor QC Testing QA Review Stimulation with antiCD3/anti-CD28 Dynal Beads, seed Baxter gas permeable culture bag Final Activated T Cell Product Patients enrolling in clinical trials or their donors undergo leukapheresis at the Hospital Blood Bank. Particular populations of cells can be enriched or isolated in the laboratory. Gambro Elutra Increasing rate of Buffer Flow Gambro Elutra for Monocyte Isolation Gambro Elutra • Procedure modified for optimal lymphocyte collection based on company experience with settings for optimal monocyte collection • Company provided: – multi-day technical training – Feedback on data collected during validation runs – Letter of cross-reference to DMF Activated T Cell Processing Flow Day 0 Leukocyte Apheresis Day ~10 Remove Beads (Baxter Maxsep) Harvester (Baxter Fenwal) Gambro Elutra depletion of monocytes Day 3 to 5 Seed WAVE Bioreactor QC Testing QA Review Stimulation with antiCD3/anti-CD28 Dynal Beads, seed Baxter gas permeable culture bag Final Activated T Cell Product T Cell Activation with Antibody Coated Beads JJ Immunol Immunol 1997; 1997; 159: 159: 5921 5921 Science Science 1997; 1997; 276: 276: 273 273 Immunol Immunol.. Rev. Rev. 1997; 1997; 160: 160: 43 43 Mol. Mol. Ther Ther.. 2004; 2004; 9; 9; 902 902 T o ta l C e lls Polyclonal Replicative Potential of Adult CD4 T Cells In Vitro 1E+20 1E+19 1E+18 1E+17 1E+16 1E+15 1E+14 1E+13 1E+12 1E+11 1E+10 1E+09 1E+08 1E+07 1E+06 IL-2 Added Day 49 No IL-2 Day 50 Exponential growth (days) 60-100 Mean log10 growth (fold) 9-12 Mean Pop Doubling 30-40 0 10 20 30 40 50 60 70 80 90 100 Day Nc020795.xls Activated T Cell Processing Flow Day 0 Leukocyte Apheresis Day ~10 Remove Beads (Baxter Maxsep) Harvester (Baxter Fenwal) Gambro Elutra depletion of monocytes Day 3 to 5 Seed WAVE Bioreactor QC Testing QA Review Stimulation with cell-based aAPC’s, seed Baxter gas permeable culture bag Final Activated T Cell Product Off-the-Shelf Dendritic Cell Substitute: reagent for the in vitro expansion of T lymphocytes Polyclonal T Cell Stimulation with LV-aAPC CD8 CD8 CD8 10,000 RADS Polyclonal stimulation CD6 es l u y: lec r a ibr mo l LV stim ines •co tok •cy CD8 28 4 CD64 LV-a APC (KT6 4) CD8 Polyclonal CD8 Stimulation CD28 TCR 3 CD3 CD8 Next Generation: Cell-Based Artificial APC LV-aAPC T Cell 2 microns Suhoski et al. Molecular Therapy 15:981-8, 2007 Baxter Lifecell Flasks- gas permeable bags Activated T Cell Processing Flow Day 0 Leukocyte Apheresis Day ~10 Remove Beads (Baxter Maxsep) Harvester (Baxter Fenwal) Gambro Elutra depletion of monocytes Day 3 to 5 Seed WAVE Bioreactor QC Testing QA Review Stimulation with antiCD3/anti-CD28 Dynal Beads, seed Baxter gas permeable culture bag Final Activated T Cell Product WAVE Biotech Bioreactor WAVE Feed and Harvest via Perfusion Small (0.1 to 5 liter) Wave Bioreactor SYSTEM 2/10 Wave 2/10 perfusion w/pinch valves WAVE Parameters • Day of seeding after transduction and vector wash • Cell concentration • Rock rate, rock angle • Media perfusion rate • Media formulation (ARV, foaming, IL-2, supplements • Nutrient usage, metabolite production Small Scale Flask vs WAVE Population Doubling Level 10 8 Small Scale WAVE PDL 6 4 2 0 -2 0 1 2 3 4 5 Days of Culture 6 7 8 9 Lifecell Static vs WAVE Population Doubling Level 5.00 4.00 PDL 3.00 2.00 C1-Wave C2-Lifecell 1.00 0.00 -1.00 0 1 2 3 4 5 6 -2.00 Day of Culture 7 8 9 10 WAVE Bioreactor • Company provided: – some technical training – Protocols, manuals, references available on website – Letter of cross-reference to DMF • References directly applicable to CD3/CD28 stimulated T cells – Hami LS, Green C, Leshinsky N, Markham E, Miller K, Craig S: GMP production and testing of Xcellerated T Cells for the treatment of patients with CLL. Cytotherapy (2004); 6(6):554-562. – Hami L, et.al. Comparison of a Static Process and a Bioreactor-based Process for the GMP Manufacture of Autologous Xcellerated T Cells for Clinical Trials. BioProcessing (2003); 2(6):1-10. Activated T Cell Processing Flow Day 0 Leukocyte Apheresis Day ~10 Remove Beads (Baxter Maxsep) Harvester (Baxter Fenwal) Gambro Elutra depletion of monocytes Day 3 to 5 Seed WAVE Bioreactor QC Testing QA Review Stimulation with antiCD3/anti-CD28 Dynal Beads, seed Baxter gas permeable culture bag Final Activated T Cell Product Baxter MaxSep The magnetic beads used to grow the T cells must be removed prior to reinfusing the cells to the patient. The cell culture is passed Baxter MaxSep magnets where the beads are retained and the cells flow through. Activated T Cell Processing Flow Day 0 Leukocyte Apheresis Day ~10 Remove Beads (Baxter Maxsep) Harvester (Baxter Fenwal) Gambro Elutra depletion of monocytes Day 3 to 5 Seed WAVE Bioreactor QC Testing QA Review Stimulation with antiCD3/anti-CD28 Dynal Beads, seed Baxter gas permeable culture bag Final Activated T Cell Product Fenwal (former subsidiary of Baxter) Harvester Built on apheresis machine CS3000 frame. Concentrates and washes cells at up to 700mls per minute continuous flow, we run at 300-400 mls per minute to increase cell yield. cells per minute depends on starting concentration. If static bag @ 1E+06/ml = 3-7E+09 cells/minute, not including washes. If WAVE @ 10E+06/ml = 3-7E+09 cells/minute, not including washes. closed system disposable set. Cells concentrated in belt chamber, end volume ~250mls Fenwal Harvester Reservoir set, Manifold set, and Harvester set The volume of the cell culture can be as much as 10 liters (2.5 gallons) or more depending on cell dose. The cells are washed out of culture media, concentrated and resuspended into 250mls (8 oz) infusible solution. Fenwal Harvester • Company initially provided: – some technical training – Repair/PM service – Manual • Current status – No longer manufactured (~10 years) – No technical, scientific, regulatory support – Kits no longer manufactured (mid-2008?) – Absence of comparable devices Autotransfusion devices as an alternative? • Different requirements for 351 vs 361? • Following validation, submit data in IND annual report or ammendment?